Health Care/Hospital
Kangpu to Present Latest Study Results of epaldeudomide (KPG-818) at the 67th ASH Annual Meeting
HEFEI, China, Nov. 18, 2025 /PRNewswire/ -- Kangpu Biopharmaceuticals announced today that the company will deliver a poster presentation to highlight the Phase I clinical trial results of epaldeudomide (KPG-818) for the treatment of hematological malignancies at the 67th American Society of Hema...
2025-11-18 21:00
1015
Taiwan's CMUH Completes HIMSS "Grand Slam," Achieving DIAM Stage 7 Certification
TAICHUNG, Nov. 17, 2025 /PRNewswire/ -- China Medical University Hospital (CMUH) has secured one of the world's highest honors in digital health, becoming the first hospital inTaiwan to achieve Stage 7 certification under the HIMSS Digital Imaging Adoption Model (DIAM). The designation, awarded b...
2025-11-18 09:01
1016
Bambusa Therapeutics Announces Completion of Series A-2 Financing to Accelerate Next-Generation Bispecific Programs
BOSTON, Nov. 17, 2025 /PRNewswire/ -- Bambusa Therapeutics, Inc. ("Bambusa"), a clinical-stage biotechnology company pioneering next-generation bispecific antibodies for immunology and inflammation (I&I), today announced the completion of its oversubscribed Series A-2 financing, closed at a subst...
2025-11-17 22:15
1111
Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion
Exciting Data on Cardiovalve Tricuspid Valve Replacement Device Presented at PCR London Valves 2025 meeting. LONDON, Nov. 17, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (2500.HK) today announced that Cardiovalve has submitted the CE technical file for its transcatheter tricuspid valve re...
2025-11-17 17:00
909
Akeso's Bispecific Antibody Targeting Aβ and BBB-Expressed Receptor Approved for Alzheimer's Disease Clinical Trials in China
HONG KONG, Nov. 16, 2025 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) announced that its AK152, a novel bispecific antibody targeting both amyloid-beta (Aβ) and blood-brain barrier (BBB) expressed receptor, has been granted approval by the National Medical Products Administration (NMPA) to initiat...
2025-11-17 10:29
1677
MATELASER Launches W1 REGEN Series -- The World's Lightest Wearable Medical-Grade Cold Laser for Deep Tissue Healing
MIAMI, Fla., Nov. 14, 2025 /PRNewswire/ -- MATELASER, INC., an FDA-certified U.S. manufacturer of therapeutic laser systems, today announced the crowdfunding debut of its W1 REGEN Series, including W1 REGEN and W1 REGEN ULTRA. Weighing only 24 grams per module, the W1 REGEN is the world's lightes...
2025-11-15 00:00
2974
PRISM BioLab Achieved Initial Milestone and Receives the Milestone Payment in Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd.
TOKYO, Nov. 14, 2025 /PRNewswire/ -- PRISM BioLab, Co. Ltd. ("PRISM") announces that today, PRISM and Ono Pharmaceutical Co., Ltd. (Headquarters:Osaka; President and COO:Toichi Takino; hereinafter "Ono") have achieved the initial milestone in the drug discovery collaboration and PRISM has confirm...
2025-11-14 16:00
1180
Smartee Demonstrates World-Class Manufacturing Capacity to Support Global Growth
SHANGHAI, Nov. 14, 2025 /PRNewswire/ -- Smartee Denti-Technology has showcased its world-class production system, designed to meet the increasing demand for its clear aligner products across the globe. With cutting-edge technology and robust manufacturing capabilities, Smartee supports its global...
2025-11-14 14:44
1169
Shangpu Group Issues Authoritative Market Position Statement Recognizing Konjac Brother as the Pioneer of Xi'an Konjac Cold Noodles
BEIJING, Nov. 14, 2025 /PRNewswire/ -- Healthy food products grown in the konjac fields of Ankang,China, are gaining traction among international consumers, driven by Konjac Brother, a fast-growing Chinese food company committed to product innovation and health-focused foods. In a recent develop...
2025-11-14 14:00
844
Zhang Xinyuan Hosts Two Vimi Wellness Ambassador Advancement Contests Within a Year, Attracting Over 3,000 Chinese Women
BOAO, China, Nov. 13, 2025 /PRNewswire/ -- The "Vimi Wellness Ambassador Advancement Contest," hosted by Ms. Zhang Xinyuan, a well-known Chinese gender relationship expert and founder of the Vimi Wellness brand, was successfully held inHainan, China, in June and October 2025. The series of contes...
2025-11-14 09:26
1116
Datasea Reports First Quarter Gross Profit of $1.2 Million, a 4.9x Increase Year-Over-Year in its Strategy to Achieve High-Tech Product Profitability
Gross Margin Rose to 8.5% through High-Tech Products Mix and Cost Efficiencies BEIJING, Nov. 13, 2025 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), aNevada-based high-tech enterprise engaged in acoustic technologies and AI multimodal digitalization, today announces its...
2025-11-13 22:31
4028
LISCure Expands Global Partnerships for BBB Shuttle Platform 'ExoPN-101'; Signs Fourth MTA with Leading Pharma Partner
SEOUL, South Korea, Nov. 13, 2025 /PRNewswire/ -- LISCure Biosciences ("LISCure"), a biotechnology company advancing next-generation therapeutics, today announced that it has entered into a new Material Transfer Agreement (MTA) with a leading global pharmaceutical company for its proprietary blo...
2025-11-13 21:00
1121
Medical AI Company VUNO Reports Profit in Q3, Driven by DeepCARS Growth
- 11 Consecutive Quarters of Revenue Growth; Q3 Revenue Exceeds KRW 10 billion for the First Time SEOUL, South Korea, Nov. 12, 2025 /PRNewswire/ -- VUNO Inc., a global medical AI company, announced that it was profitable in the third quarter of 2025, recording consolidated revenue ofKRW 10.8 bil...
2025-11-13 09:47
1132
Medit and OraQ Announce Strategic Partnership to Advance AI-Driven Intelligence in Digital Dentistry
Collaboration unites two leaders in innovation to redefine how clinical insight is delivered across the dental ecosystem NEWPORT BEACH, Calif., Nov. 12, 2025 /PRNewswire/ -- Medit, a global leader in 3D intraoral scanning solutions, and OraQ, a pioneer in AI-powered clinical intelligence, today ...
2025-11-12 21:00
1401
EirGenix Signed The Commercial Licensing Agreement for Its Second HER2 Biosimilar Asset EG1206A
TAIPEI, Nov. 12, 2025 /PRNewswire/ -- EirGenix Inc.(TWSE: 6589) today announced that it has entered into a second global exclusive licensing agreement with international biosimilar leader Sandoz AG (SIX:SDZ/OTCQX:SDZNY) for the commercialization of its independently developed breast cancer biosim...
2025-11-12 20:47
1507
CureGene Unveils Groundbreaking Preclinical Data for CG-0416, a Novel Oral Non-GLP-1 Therapy, at Obesity Week 2025
CG-0416, a highly liver-targeted THR-β agonist, demonstrates high-quality weight loss by reducing fat mass while preserving muscle, both as a monotherapy and in combination withGLP-1 RAs. ATLANTA, Nov. 11, 2025 /PRNewswire/ -- CureGene Pharmaceuticals ("CureGene") today announced the first discl...
2025-11-12 06:24
2124
Mabwell's Novel Anti‑IL‑11 Monoclonal Antibody 9MW3811 Approved by NMPA to Initiate Phase II Clinical Trial in Pathological Scarring
SHANGHAI, Nov. 11, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that its novel anti‑IL‑11 monoclonal antibody 9MW3811 has received approval from the China National Medical Products Administration (NMPA) to initiate...
2025-11-11 22:00
1937
From Bangkok to the World: Aura Bangkok Clinic Showcases International Standards in Aesthetic Care
BANGKOK, Nov. 11, 2025 /PRNewswire/ -- Aura Bangkok Clinic, a leader in Thailand's medical aesthetic industry, is enhancing the country's reputation as a top destination for Thai beauty medical tourism through its global expertise, award-winning services, and internationally recognized training p...
2025-11-11 22:00
1300
Strategic Partnership Between Sanyou Bio and Yugong Bio to Accelerate Expansion in High-End Synthetic Enzyme Market
SHANGHAI, Nov. 11, 2025 /PRNewswire/ -- Sanyou Bio and Yugong Bio today announced the signing of a strategic cooperation agreement. This powerful alliance marks a significant step to deepen their collaboration in the development of high-end synthetic molecular enzymes. This collaboration is base...
2025-11-11 22:00
2139
Coreline Soft Selected as Exclusive AI Provider for France's National Lung Cancer Screening Pilot Project, IMPULSION
- APHP-led IMPULSION project secures Coreline Soft as sole AI supplier
- UGAP (France's central public procurement agency) registration completed,
opening opportunities withFrance's largest public hospitals
SEOUL, South Korea, Nov. 11, 2025 /PRNewswire/ -- Coreline Soft
2025-11-11 21:00
1178
Week's Top Stories
Most Reposted
DBS is First Bank in Asia Pacific to Pilot Visa Intelligent Commerce for Everyday Payments
[Picked up by 321 media titles]
2026-02-16 10:00
Ascentium Acquires Clara, Expanding into the Abu Dhabi Global Market (ADGM) and Strengthening its Middle East Presence
[Picked up by 310 media titles]
2026-02-12 14:00
Little Artists Art Studio, Singapore Shines at Art Capital 2026
[Picked up by 277 media titles]
2026-02-17 19:12
Tower Capital Asia announces majority investment in V-Key - a leader in digital identity and mobile application security
[Picked up by 265 media titles]
2026-02-13 01:52
Appier Delivers Record Results Driven by Agentic AI Innovation
[Picked up by 263 media titles]
2026-02-13 17:03Most Read
Datasea Reports Second Fiscal Quarter 2026 Results
2026-02-12 22:20
8443
eufy Raises the Bar for Home Cleaning with Omni C28, Delivering One-Pass-Clean Performance with HydroJet™ Self-Clean Roller Mop
2026-02-14 10:00
7600
NYSE Content Update: Forgent Power Solutions, Post IPO, to Ring Opening Bell
2026-02-12 21:56
7150
